ELAN Elanco Animal Health Incorporated Common Stock
NYSE · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 5, 2026 10-K/10-Q 八月 5, 2026ELAN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
ELAN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | ELAN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -55.45年均值 ≈-28.3 | ≈-28.3 | · | · | |
| P/S (TTM) | 2.25年均值 ≈1.9 | ≈1.9 | 11.3 | 低估 | |
| 市净率 (MRQ) | 1.75年均值 ≈1.3 | ≈1.3 | 8.8 | 低估 | |
| 股价/自由现金流 (TTM) | 29.25年均值 ≈33.4 | ≈33.4 | · | · | |
| 市现率 (TTM) | 18.05年均值 ≈19.8 | ≈19.8 | 23.0 | 公允价值 | |
| 市净率(有形资产) (MRQ) | 3.3 | · | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ELAN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 55.4% | · | · | · | |
| EBITDA Margin (息税折旧摊销前利润率) | 14.4%5年均值 ≈15.1% | ≈15.1% | 8.7% | 顶尖 | |
| 税前利润率 (TTM) | -3.3%5年均值 ≈-6.9% | ≈-6.9% | 13.4% | 弱 | |
| 净利润率 (TTM) | -4.0%5年均值 ≈-7.4% | ≈-7.4% | 12.0% | 弱 | |
| ROA (TTM) | -1.5%5年均值 ≈-2.2% | ≈-2.2% | 2.0% | 弱 | |
| ROE (TTM) | -3.0%5年均值 ≈-5.1% | ≈-5.1% | -3.5% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ELAN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 2.15年均值 ≈2.3 | ≈2.3 | 2.2 | 低流动性 | |
| Quick Ratio (速动比率) | 0.95年均值 ≈0.9 | ≈0.9 | 1.3 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ELAN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 6.2%5年均值 ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 2.2%5年均值 ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 7.6% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ELAN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.45年均值 ≈0.3 | ≈0.3 | 0.7 | 弱 | |
| Inventory Turnover (库存周转率) | 1.35年均值 ≈1.3 | ≈1.3 | 1.2 | 持平 | |
| Receivables Turnover (应收账款周转率) | 5.65年均值 ≈5.5 | ≈5.5 | 5.5 | 持平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数(报告的 headcount,yfinance)。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$501.6K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $0.34 | $0.27 | 23.8% |
| 2026年3月31日 | 五月 13, 2026 | $0.40 | $0.35 | 13.4% |
| 2025年12月31日 | $0.13 | $0.11 | 15.0% | |
| 2025年9月30日 | $0.19 | $0.13 | 43.0% | |
| 2025年6月30日 | $0.26 | $0.20 | 30.5% | |
| 2025年3月31日 | $0.37 | $0.32 | 17.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B | $2.89B | |
| Cost of Revenue | $2.12B | $2.00B | $1.93B | $1.91B | $2.13B | $1.67B | $1.47B | $1.57B | $1.49B | |
| Gross Profit | $2.59B | $2.44B | $2.49B | · | · | · | · | · | · | |
| R&D Expense | $368M | $344M | $327M | $321M | $369M | $329M | $270M | $247M | $252M | |
| SG&A Expense | $1.43B | $1.31B | $1.28B | $1.26B | $1.40B | $997M | $760M | $735M | $780M | |
| Operating Expenses | · | $3.95B | $5.61B | $4.48B | $5.33B | $3.95B | $2.99B | · | · | |
| Interest Expense | · | · | $277M | $241M | $236M | $150M | $79M | $30M | $0 | |
| Interest Income | $43M | $31M | $4M | · | · | · | · | · | · | |
| Other Non-op | · | · | $-75M | $-32M | $-5M | $178M | $-28M | $-41M | $100.0K | |
| Pretax Income | $-224M | $488M | $-1.20B | $-72M | $-571M | $-677M | $78M | $114M | $-233M | |
| Income Tax | $8M | $150M | $36M | $6M | $-88M | $-103M | $10M | $28M | $78M | |
| Net Income | $-232M | $338M | $-1.23B | $-78M | $-483M | $-574M | $68M | $86M | $-311M | |
| EPS (Basic) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | $-1.06 | |
| EPS (Diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | $-1.06 | |
| Shares (Basic) | 496,400,000 | 494,000,000 | 492,300,000 | 488,300,000 | 487,200,000 | 441,400,000 | 369,000,000 | 313,700,000 | 293,300,000 | |
| Shares (Diluted) | 496,400,000 | 497,300,000 | 492,300,000 | 488,300,000 | 487,200,000 | 441,400,000 | 370,300,000 | 313,700,000 | 293,300,000 | |
| EBITDA | $680M | $662M | $694M | $682M | $716M | $517M | $314M | $296M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $468M | $352M | $345M | $638M | $495M | $334M | $475M | $323M | |
| Receivables | $873M | $805M | $842M | $797M | $833M | $872M | $817M | $652M | $567M | |
| Inventory | $1.74B | $1.57B | $1.74B | $1.54B | $1.37B | $1.58B | $1.05B | $1.00B | $1.06B | |
| Prepaid Expense | $236M | $287M | $310M | $394M | $237M | $256M | $87M | $114M | $136M | |
| Current Assets | $3.46B | $3.21B | $3.41B | $3.28B | $3.27B | $3.42B | $2.37B | $2.50B | $2.12B | |
| PP&E (Net) | $1.41B | $993M | $1.03B | $999M | $1.05B | $1.32B | $955M | $922M | $920M | |
| PP&E (Gross) | · | $1.85B | $1.84B | $1.72B | $2.10B | · | · | $1.80B | $1.75B | |
| Accum. Depreciation | · | $858M | $815M | $723M | $1.04B | $1.04B | $930M | $879M | $834M | |
| Goodwill | $4.78B | $4.41B | $5.09B | $5.99B | $6.17B | $6.22B | $2.99B | $2.96B | $3.00B | |
| Intangibles | $3.41B | $3.68B | $4.49B | $4.84B | $5.59B | $6.39B | $2.48B | $2.50B | $2.67B | |
| Other Non-current Assets | $304M | $311M | $341M | $378M | $390M | $348M | $185M | $67M | $242M | |
| Total Assets | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B | $17.69B | $8.99B | $8.96B | $8.94B | |
| Accounts Payable | $368M | $296M | $270M | $390M | $416M | $501M | $223M | $205M | $204M | |
| Current Liabilities | $1.60B | $1.31B | $1.24B | $1.70B | $1.65B | $2.08B | $818M | $971M | $643M | |
| Capital Leases | $86M | $92M | $110M | $111M | $127M | $151M | $62M | · | · | |
| Deferred Tax | $382M | $449M | $567M | $662M | $765M | $900M | $101M | $115M | $252M | |
| Other Non-current Liabilities | $585M | $302M | $411M | $229M | $262M | $322M | $107M | $122M | $126M | |
| Total Liabilities | $6.81B | $6.52B | $8.14B | $8.20B | $8.97B | $9.22B | $3.44B | $3.76B | $1.16B | |
| Long-term Debt | $3.76B | $4.32B | $5.77B | $5.84B | $6.32B | $6.13B | $2.35B | $2.47B | $0 | |
| Total Debt | · | $4.32B | $5.77B | $5.84B | $6.32B | $6.13B | $2.35B | $2.47B | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $8.87B | $8.82B | $8.78B | $8.74B | $8.70B | $8.65B | $5.64B | $5.40B | $0 | |
| Retained Earnings | $-2.18B | $-1.95B | $-2.29B | $-1.06B | $-979M | $-477M | $84M | $16M | $0 | |
| AOCI | $-141M | $-771M | $-266M | $-392M | $-209M | $303M | $-174M | $-222M | $-257M | |
| Stockholders' Equity | $6.55B | $6.10B | $6.22B | $7.29B | $7.51B | $8.46B | $5.54B | $5.20B | $7.78B | |
| Liabilities + Equity | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B | $17.69B | $8.99B | $8.96B | $8.94B | |
| Shares Outstanding | 496,975,154 | 494,400,000 | 492,800,000 | 474,200,000 | 473,100,000 | 471,900,000 | 373,000,000 | 365,643,911 | 365,625,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $680M | $662M | $694M | $682M | $716M | $517M | $314M | $296M | $318M | |
| Stock-based Comp | $68M | $55M | $46M | $59M | $66M | $47M | $49M | $26M | $25M | |
| Deferred Tax | $-134M | $-112M | $-80M | $-57M | $-148M | $-114M | $0 | $-61M | $-13M | |
| Amort. of Intangibles | $543M | $527M | $548M | $528M | $556M | $360M | $200M | $197M | $221M | |
| Restructuring | $156M | $44M | $0 | $-7M | $110M | $157M | $19M | $27M | $194M | |
| Other Non-cash | $178M | $-402M | $842M | $-154M | $327M | $79M | $-208M | $140M | · | |
| Operating Cash Flow | $560M | $541M | $271M | $452M | $483M | $-41M | $224M | $487M | $174M | |
| CapEx | $276M | $147M | $140M | $171M | $159M | $135M | $140M | $134M | $99M | |
| Investing Cash Flow | $-279M | $1.16B | $-169M | $-179M | $-530M | $-4.78B | $-235M | $-127M | $-965M | |
| Stock Issued | · | · | $0 | $425M | $500M | $1.22B | $0 | $1.66B | $0 | |
| Net Stock Activity | · | · | $0 | $0 | $0 | $1.22B | $0 | $1.66B | · | |
| Financing Cash Flow | $-275M | $-1.49B | $-83M | $-549M | $210M | $4.95B | $-305M | $-35M | $848M | |
| Net Change in Cash | $77M | $116M | $7M | $-293M | $132M | $161M | $-333M | $354M | $65M | |
| Taxes Paid | $225M | $140M | $95M | $93M | $151M | $97M | $43M | $27M | $36M | |
| Free Cash Flow | $284M | $394M | $131M | $315M | $357M | $-176M | $84M | $353M | · | |
| Levered FCF | · | · | $-154M | $54M | $161M | $-300M | $15M | $330M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.0% | · | · | · | · | · | · | · | · | |
| Net Margin | -4.9% | 7.6% | -27.9% | -1.8% | -9.9% | -17.1% | 2.2% | 2.8% | · | |
| Pretax Margin | -4.8% | 11.0% | -27.1% | -1.6% | -11.9% | -20.5% | 2.5% | 3.7% | · | |
| EBITDA Margin | 14.4% | 14.9% | 15.7% | 15.5% | 15.0% | 15.8% | 10.2% | 9.7% | · | |
| ROA | -1.8% | 2.5% | -8.2% | -0.49% | -2.8% | -4.2% | 0.76% | 0.97% | · | |
| ROE | -3.5% | 5.4% | -19.9% | -1.1% | -6.2% | -6.7% | 1.2% | 1.7% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.4 | 2.7 | 1.9 | 2.0 | 1.6 | 2.9 | 2.6 | · | |
| Quick Ratio | 0.9 | 1.0 | 1.0 | 0.7 | 0.9 | 0.7 | 1.4 | 1.2 | · | |
| Debt / Equity | · | 0.7 | 0.9 | 0.8 | 0.8 | 0.7 | 0.4 | 0.5 | · | |
| LT Debt / Equity | · | 0.7 | 0.9 | 0.7 | 0.8 | 0.7 | 0.4 | 0.5 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | · | |
| Inventory Turnover | 1.3 | 1.2 | 1.2 | 1.3 | 1.4 | 1.3 | 1.4 | 1.5 | · | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.4 | 5.6 | 3.9 | 4.2 | 5.0 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.17 | $12.33 | $12.63 | $15.37 | $15.93 | $17.96 | $14.87 | $14.21 | · | |
| Revenue / Share | $9.50 | $8.93 | $8.97 | $9.03 | $9.78 | $7.42 | $8.29 | · | · | |
| Cash Flow / Share | $1.13 | $1.09 | $0.55 | $0.93 | $0.99 | $-0.09 | $0.61 | · | · | |
| Cash / Share | $1.10 | $0.95 | $0.71 | $0.73 | $1.35 | $1.05 | $0.90 | $1.30 | · | |
| EPS (TTM) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.2% | 0.50% | 0.14% | -7.4% | 45.6% | · | · | · | · | |
| Revenue CAGR 3Y | 2.2% | -2.3% | 10.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.6% | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B | · | |
| Net Income TTM | $-232M | $338M | $-1.23B | $-78M | $-483M | $-574M | $68M | $86M | · | |
| Market Cap | $11.25B | $5.99B | $7.34B | $5.80B | $13.43B | $14.47B | $10.99B | $11.53B | · | |
| Enterprise Value | · | $9.84B | $12.77B | $11.29B | $19.11B | $20.11B | $13.01B | $13.53B | · | |
| P/E | -48.1 | 17.8 | -6.0 | -76.4 | -28.7 | -23.6 | 163.6 | 112.6 | · | |
| P/S | 2.4 | 1.3 | 1.7 | 1.3 | 2.8 | 4.4 | 3.6 | 3.8 | · | |
| P/B | 1.7 | 1.0 | 1.2 | 0.8 | 1.8 | 1.7 | 2.0 | 2.2 | · | |
| P / Cash Flow | 20.1 | 11.1 | 27.1 | 12.8 | 27.8 | -353.0 | 49.0 | 23.7 | · | |
| P / FCF | 39.6 | 15.2 | 56.1 | 18.4 | 37.6 | -82.4 | 131.2 | 32.7 | · | |
| EV / EBITDA | · | 14.9 | 18.4 | 16.5 | 26.7 | 38.9 | 41.4 | 45.7 | · | |
| EV / FCF | · | 25.0 | 97.4 | 35.8 | 53.5 | -114.5 | 155.4 | 38.3 | · | |
| EV / Revenue | · | 2.2 | 2.9 | 2.6 | 4.0 | 6.1 | 4.2 | 4.4 | · | |
| Earnings Yield | -2.1% | 5.6% | -16.8% | -1.3% | -3.5% | -4.2% | 0.61% | 0.89% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.37B | $1.14B | $1.14B | $1.24B | $1.19B | $1.02B | $1.03B | $1.18B | $1.21B | $1.03B | $1.07B | $1.06B | $1.26B | $984M | $1.03B | |
| Cost of Revenue | $570M | $586M | $555M | $530M | $528M | $509M | $501M | $492M | $495M | $515M | $516M | $487M | $434M | $494M | $448M | $472M | |
| Gross Profit | $798M | $785M | $589M | $607M | $713M | $684M | $519M | $538M | $689M | $690M | · | · | · | · | · | · | |
| R&D Expense | $92M | $97M | $93M | $89M | $92M | $94M | $81M | $87M | $89M | $87M | $79M | $86M | $81M | $81M | $80M | $78M | |
| SG&A Expense | $449M | $381M | $338M | $351M | $400M | $341M | $300M | $323M | $354M | $337M | $292M | $313M | $353M | $327M | $301M | $298M | |
| Operating Expenses | · | · | · | · | · | · | · | $471M | $1.22B | $1.19B | · | $2.17B | $1.14B | $1.15B | $1.07B | $1.07B | |
| Interest Expense | · | · | · | · | · | · | · | $58M | $65M | $66M | · | $72M | $74M | $64M | · | $60M | |
| Other Non-op | · | · | · | · | · | · | · | $-1M | $-2M | $-9M | · | $-9M | $-23M | $-9M | · | $-8M | |
| Pretax Income | $56M | $87M | $-259M | $-50M | $25M | $60M | $-51M | $559M | $-32M | $12M | $-127M | $-1.10B | $-79M | $108M | $-89M | $-44M | |
| Income Tax | $2M | $30M | $17M | $-16M | $14M | $-7M | $-43M | $195M | $18M | $-20M | $14M | $-1M | $18M | $5M | $-35M | $21M | |
| Net Income | $54M | $57M | $-276M | $-34M | $11M | $67M | $-8M | $364M | $-50M | $32M | $-141M | $-1.10B | $-97M | $103M | $-54M | $-65M | |
| EPS (Basic) | $0.11 | $0.11 | $-0.56 | $-0.07 | $0.02 | $0.14 | $-0.02 | $0.74 | $-0.10 | $0.06 | $-0.29 | $-2.22 | $-0.20 | $0.21 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $0.11 | $0.11 | $-0.55 | $-0.07 | $0.02 | $0.13 | $-0.01 | $0.73 | $-0.10 | $0.06 | $-0.29 | $-2.22 | $-0.20 | $0.21 | $-0.11 | $-0.13 | |
| Shares (Basic) | 499,500,000 | 497,700,000 | · | 496,800,000 | 496,600,000 | 495,100,000 | · | 494,300,000 | 494,200,000 | 493,200,000 | · | 492,700,000 | 492,600,000 | 491,100,000 | · | 488,400,000 | |
| Shares (Diluted) | 505,900,000 | 506,000,000 | · | 496,800,000 | 500,100,000 | 499,100,000 | · | 497,700,000 | 494,200,000 | 496,000,000 | · | 492,700,000 | 492,600,000 | 492,800,000 | · | 488,400,000 | |
| EBITDA | · | $172M | · | · | · | $161M | · | · | · | $166M | · | · | · | $173M | · | · |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $530M | $428M | $545M | $505M | $539M | $487M | $468M | $490M | $416M | $345M | · | $369M | $367M | $318M | · | $460M | |
| Receivables | $1.08B | $1.08B | $873M | $894M | $989M | $970M | $805M | $840M | $999M | $988M | · | $911M | $1.00B | $1.05B | · | $804M | |
| Inventory | $1.77B | $1.72B | $1.74B | $1.71B | $1.67B | $1.59B | $1.57B | $1.63B | $1.61B | $1.64B | · | $1.69B | $1.69B | $1.60B | · | $1.34B | |
| Prepaid Expense | $346M | $285M | $236M | $305M | $302M | $301M | $287M | $340M | $277M | $338M | · | $371M | $370M | $370M | · | $326M | |
| Current Assets | $3.80B | $3.58B | $3.46B | $3.49B | $3.61B | $3.44B | $3.21B | $3.37B | $4.01B | $4.05B | · | $3.56B | $3.65B | $3.55B | · | $3.15B | |
| PP&E (Net) | $1.41B | $1.40B | · | $1.39B | $1.36B | $1.05B | · | $979M | $949M | $949M | · | $992M | $1.01B | $1.00B | · | $936M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $744M | · | $696M | |
| Goodwill | $4.84B | $4.72B | $4.78B | $4.76B | $4.76B | $4.51B | $4.41B | $4.62B | $4.48B | $4.48B | $5.09B | $4.90B | $6.04B | $6.06B | $5.99B | $5.72B | |
| Intangibles | $3.20B | $3.23B | $3.41B | $3.60B | $3.71B | $3.63B | $3.68B | $4.01B | $4.00B | $4.20B | · | $4.47B | $4.68B | $4.79B | · | $4.77B | |
| Other Non-current Assets | $304M | $295M | $304M | $306M | $308M | $312M | $311M | $302M | $324M | $346M | · | $410M | $419M | $369M | · | $376M | |
| Total Assets | $13.56B | $13.22B | $13.36B | $13.55B | $13.74B | $12.94B | $12.61B | $13.28B | $13.76B | $14.02B | · | $14.34B | $15.80B | $15.77B | · | $14.95B | |
| Accounts Payable | $427M | $372M | $368M | $352M | $368M | $330M | $296M | $259M | $291M | $302M | · | $296M | $354M | $381M | · | $350M | |
| Current Liabilities | $1.85B | $1.66B | $1.60B | $1.46B | $1.39B | $1.27B | $1.31B | $1.32B | $1.37B | $1.23B | · | $1.26B | $1.28B | $1.58B | · | $1.61B | |
| Capital Leases | · | · | $86M | · | · | · | $92M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $410M | $366M | $382M | $478M | $496M | $481M | $449M | $539M | $524M | $530M | · | $643M | $658M | $663M | · | $618M | |
| Other Non-current Liabilities | $551M | $467M | $427M | $607M | $638M | $487M | $302M | $587M | $465M | $474M | · | $432M | $411M | $245M | · | $225M | |
| Total Liabilities | $6.97B | $6.72B | $6.81B | $6.80B | $6.97B | $6.59B | $6.52B | $6.76B | $7.82B | $7.96B | · | $8.21B | $8.38B | $8.29B | · | $8.20B | |
| Long-term Debt | $3.66B | $3.74B | $3.76B | $3.77B | $3.95B | $4.39B | $4.32B | $4.36B | $5.68B | $5.76B | · | $5.91B | $6.06B | $6.02B | · | $5.90B | |
| Total Debt | · | · | · | · | · | $4.39B | · | $4.36B | $5.68B | $5.76B | · | $5.91B | $6.06B | $6.02B | · | $5.90B | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Paid-in Capital | $8.88B | $8.86B | $8.87B | $8.85B | $8.84B | $8.82B | $8.82B | $8.80B | $8.79B | $8.78B | · | $8.76B | $8.75B | $8.74B | · | $8.72B | |
| Retained Earnings | $-2.07B | $-2.12B | $-2.18B | $-1.91B | $-1.87B | $-1.88B | $-1.95B | $-1.94B | $-2.31B | $-2.26B | · | $-2.15B | $-1.05B | $-954M | · | $-972M | |
| AOCI | $-219M | $-233M | $-141M | $-199M | $-192M | $-583M | $-771M | $-339M | $-542M | $-465M | · | $-482M | $-281M | $-310M | · | $-1.01B | |
| Stockholders' Equity | $6.59B | $6.50B | $6.55B | $6.75B | $6.78B | $6.35B | $6.10B | $6.52B | $5.94B | $6.06B | $6.22B | $6.13B | $7.42B | $7.48B | $7.29B | $6.75B | |
| Liabilities + Equity | $13.56B | $13.22B | $13.36B | $13.55B | $13.74B | $12.94B | $12.61B | $13.28B | $13.76B | $14.02B | · | $14.34B | $15.80B | $15.77B | · | $14.95B | |
| Shares Outstanding | 499,549,698 | 499,381,644 | 496,975,154 | 496,830,457 | 496,646,312 | 496,458,420 | 494,445,839 | 494,333,072 | 494,182,138 | 494,049,915 | 492,800,000 | 492,683,420 | 492,554,242 | 492,418,216 | 474,200,000 | 474,124,115 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $171M | $172M | $174M | $176M | $169M | $161M | $164M | $170M | $162M | $166M | $171M | $173M | $177M | $173M | $168M | $167M | |
| Stock-based Comp | $20M | $21M | $16M | $17M | $20M | $15M | $15M | $15M | $14M | $11M | $15M | $10M | $9M | $12M | $15M | $13M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $-21M | $4M | |
| Amort. of Intangibles | $139M | $138M | $139M | $140M | $136M | $128M | $130M | $133M | $131M | $133M | $138M | $140M | $136M | $134M | $130M | $128M | |
| Restructuring | $3M | $-1M | $155M | $0 | $0 | $1M | $-1M | $2M | $4M | $39M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | $-500M | · | · | · | $-484M | · | · | · | $-384M | · | · | · | $-874M | · | · | |
| Operating Cash Flow | $277M | $13M | $108M | $219M | $237M | $-4M | $177M | $162M | $200M | $2M | $157M | $198M | $61M | $-145M | $13M | $189M | |
| CapEx | $33M | $51M | $62M | $92M | $57M | $65M | $47M | $42M | $34M | $24M | $41M | $33M | $46M | $24M | $100M | $26M | |
| Investing Cash Flow | $-110M | $-60M | $-64M | $-101M | $-56M | $-58M | $-90M | $1.24B | $-33M | $37M | $-35M | $-36M | $-43M | $-55M | $-76M | $-37M | |
| Financing Cash Flow | $-74M | $-65M | $-18M | $-153M | $-156M | $52M | $-32M | $-1.34B | $-93M | $-27M | $-139M | $-157M | $39M | $174M | $-84M | $-169M | |
| Net Change in Cash | $102M | $-117M | $40M | $-34M | $52M | $19M | $-22M | $74M | $71M | $-7M | $-17M | $2M | $49M | $-27M | $-115M | $-47M | |
| Free Cash Flow | · | $-38M | · | · | · | $-69M | · | · | · | $-22M | · | · | · | $-165M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-198M | · | · | · | $-226M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.3% | 57.3% | · | 53.4% | 57.5% | 57.3% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 4.0% | 4.2% | · | -3.0% | 0.89% | 5.6% | · | 35.3% | -4.2% | 2.7% | · | -102.6% | -9.2% | 8.2% | · | -4.8% | |
| Pretax Margin | 4.1% | 6.3% | · | -4.4% | 2.0% | 5.0% | · | 54.3% | -2.7% | 1.0% | · | -102.7% | -7.5% | 8.6% | · | -4.1% | |
| EBITDA Margin | · | 12.6% | · | · | · | 13.5% | · | · | · | 13.8% | · | · | · | 13.8% | · | · | |
| ROA | 0.40% | 0.44% | · | -0.25% | 0.08% | 0.50% | · | 2.6% | -0.34% | 0.21% | · | -7.5% | -0.62% | 0.64% | · | -0.31% | |
| ROE | 0.81% | 0.89% | · | -0.51% | 0.17% | 1.1% | · | 5.8% | -0.75% | 0.47% | · | -17.0% | -1.3% | 1.4% | · | -0.68% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.2 | · | 2.4 | 2.6 | 2.7 | · | 2.5 | 2.9 | 3.3 | · | 2.8 | 2.8 | 2.2 | · | 2.0 | |
| Quick Ratio | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | 1.0 | 1.1 | · | 1.0 | 1.1 | 0.9 | · | 0.8 | |
| Debt / Equity | · | · | · | · | · | 0.7 | · | 0.7 | 1.0 | 1.0 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | |
| LT Debt / Equity | · | · | · | · | · | 0.7 | · | 0.7 | 0.9 | 0.9 | · | 1.0 | 0.8 | 0.8 | · | 0.8 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.2 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.19 | $13.02 | · | $13.58 | $13.64 | $12.80 | · | $13.20 | $12.02 | $12.26 | · | $12.45 | $15.06 | $15.19 | · | $14.23 | |
| Revenue / Share | $2.70 | $2.71 | · | $2.29 | $2.48 | $2.39 | · | $2.07 | $2.40 | $2.43 | · | $2.17 | $2.15 | $2.55 | · | $2.10 | |
| Cash Flow / Share | · | $0.03 | · | · | · | $-0.01 | · | · | · | $0.00 | · | · | · | $-0.29 | · | · | |
| Cash / Share | $1.06 | $0.86 | · | $1.02 | $1.09 | $0.98 | · | $0.99 | $0.84 | $0.70 | · | $0.75 | $0.75 | $0.65 | · | $0.97 | |
| EPS (TTM) | $-0.40 | $-0.49 | · | $0.07 | $0.87 | $0.75 | · | $0.40 | $-2.55 | $-2.65 | · | $-2.32 | $-0.23 | $-0.05 | · | $-0.28 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.02B | $4.89B | · | $4.59B | $4.48B | $4.43B | · | $4.45B | $4.49B | $4.37B | · | $4.37B | $4.32B | $4.44B | · | $4.54B | |
| Net Income TTM | $-199M | $-242M | · | $36M | $434M | $373M | · | $205M | $-1.25B | $-1.30B | · | $-1.14B | $-113M | $-26M | · | $-132M | |
| Market Cap | $12.29B | $11.95B | · | $10.01B | $7.09B | $5.21B | · | $7.26B | $7.13B | $8.04B | · | $5.54B | $4.96B | $4.63B | · | $5.88B | |
| Enterprise Value | · | · | · | · | · | $9.12B | · | $11.13B | $12.39B | $13.46B | · | $11.08B | $10.65B | $10.33B | · | $11.32B | |
| P/E | -61.5 | -48.8 | · | 287.7 | 16.4 | 14.0 | · | 36.7 | -5.7 | -6.1 | · | -4.8 | -43.7 | -188.0 | · | -44.3 | |
| P/S | 2.4 | 2.4 | · | 2.2 | 1.6 | 1.2 | · | 1.6 | 1.6 | 1.8 | · | 1.3 | 1.1 | 1.0 | · | 1.3 | |
| P/B | 1.9 | 1.8 | · | 1.5 | 1.0 | 0.8 | · | 1.1 | 1.2 | 1.3 | · | 0.9 | 0.7 | 0.6 | · | 0.9 | |
| P / Cash Flow | · | 919.2 | · | · | · | -1303.2 | · | · | · | 4021.6 | · | · | · | -31.9 | · | · | |
| EV / Revenue | · | · | · | · | · | 2.1 | · | 2.5 | 2.8 | 3.1 | · | 2.5 | 2.5 | 2.3 | · | 2.5 | |
| Earnings Yield | -1.6% | -2.1% | · | 0.35% | 6.1% | 7.1% | · | 2.7% | -17.7% | -16.3% | · | -20.6% | -2.3% | -0.53% | · | -2.3% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B |
| 毛利率 % | 55.0% | · | · | · | · |
| 净收入 | $-232M | $338M | $-1.23B | $-78M | $-483M |
| 稀释后每股收益 (EPS) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | · | 0.7 | 0.9 | 0.8 | 0.8 |
| 流动比率 | 2.2 | 2.4 | 2.7 | 1.9 | 2.0 |
| 速动比率 | 0.9 | 1.0 | 1.0 | 0.7 | 0.9 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $284M | $394M | $131M | $315M | $357M |
机构持有人 (13F) 550 家申报者 · $14.2B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 77 (-36 与上一季度对比) | 70 (+15 与上一季度对比) | 163 (-31 与上一季度对比) | 214 (+64 与上一季度对比) | +27.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Dodge & Cox | $1658640785 | 67397025 | 11.66% | 股份 |
| FMR LLC | $1401510441 | 56948819 | 9.85% | 股份 |
| BlackRock, Inc. | $1202197843 | 48849973 | 8.45% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $1118401745 | 45445012 | 7.86% | 股份 |
| VANGUARD GROUP INC | $1087591712 | 48059731 | 7.65% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $625528870 | 25417271 | 4.40% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $557965598 | 22672312 | 3.92% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $556371363 | 22607532 | 3.91% | 股份 |
| STATE STREET CORP | $395311562 | 16063046 | 2.78% | 股份 |
| Winslow Capital Management, LLC | $332508835 | 13511127 | 2.34% | 股份 |
| Black Creek Investment Management Inc. | $321072396 | 13046420 | 2.26% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $278202108 | 11302057 | 1.96% | 股份 |
| UBS Group AG | $243905329 | 9910822 | 1.71% | 股份 |
| CITADEL ADVISORS LLC | $237944517 | 9668611 | 1.67% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $205635549 | 8355772 | 1.45% | 股份 |
| MORGAN STANLEY | $193295899 | 7854362 | 1.36% | 股份 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $153572314 | 6240240 | 1.08% | 股份 |
| Invesco Ltd. | $130588683 | 5306326 | 0.92% | 股份 |
| SEI INVESTMENTS CO | $130058416 | 5284773 | 0.91% | 股份 |
| JENNISON ASSOCIATES LLC | $110951603 | 4508395 | 0.78% | 股份 |
| MARSHALL WACE, LLP | $109080132 | 4432350 | 0.77% | 股份 |
| NORTHERN TRUST CORP | $104741538 | 4256056 | 0.74% | 股份 |
| JUPITER ASSET MANAGEMENT LTD | $103836456 | 4219279 | 0.73% | 股份 |
| BANK OF AMERICA CORP /DE/ | $96221913 | 3909871 | 0.68% | 股份 |
| Clearbridge Investments, LLC | $91455213 | 3716181 | 0.64% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $87444572 | 3553213 | 0.61% | 股份 |
| Bank of New York Mellon Corp | $83957796 | 3411532 | 0.59% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $77875293 | 3164376 | 0.55% | 股份 |
| BRANDES INVESTMENT PARTNERS, LP | $73141807 | 2972036 | 0.51% | 股份 |
| Artemis Investment Management LLP | $73009158 | 2966646 | 0.51% | 股份 |
| Capital World Investors | $69244517 | 2813674 | 0.49% | 股份 |
| Allspring Global Investments Holdings, LLC | $67238635 | 2791143 | 0.47% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $67084128 | 2725889 | 0.47% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $65857590 | 2676050 | 0.46% | 股份 |
| SHAPIRO CAPITAL MANAGEMENT LLC | $65251200 | 2651410 | 0.46% | 股份 |
| Douglas Lane & Associates, LLC | $63963202 | 2599074 | 0.45% | 股份 |
| BOWEN HANES & CO INC | $63349171 | 2647270 | 0.45% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $58657420 | 2383479 | 0.41% | 股份 |
| Nuveen, LLC | $53449711 | 2171870 | 0.38% | 股份 |
| Freestone Grove Partners LP | $53420459 | 2170681 | 0.38% | 股份 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $52629706 | 2138550 | 0.37% | 股份 |
| Quantinno Capital Management LP | $48602495 | 1974908 | 0.34% | 股份 |
| JPMORGAN CHASE & CO | $48119672 | 1922899 | 0.34% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $46073784 | 1872157 | 0.32% | 股份 |
| TORONTO DOMINION BANK | $44634763 | 1813684 | 0.31% | 股份 |
| Holocene Advisors, LP | $41706985 | 1694717 | 0.29% | 股份 |
| Woodline Partners LP | $39695585 | 1612986 | 0.28% | 股份 |
| FEDERATED HERMES, INC. | $37996460 | 1543944 | 0.27% | 股份 |
| Redwood Grove Capital, LLC | $37537633 | 1525300 | 0.26% | 股份 |
| Alyeska Investment Group, L.P. | $36875132 | 1498380 | 0.26% | 股份 |
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC, Scott D. Ferguson ×2 申报 | 2022年12月22日 | · | 初始申报 | · | SEC |
| ELANCO ANIMAL HEALTH INCORPORATED ×2 申报 | 2021年8月30日 | · | 初始申报 | 并购/出售 | SEC |
| OR ×3 申报 | 2020年12月15日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 35 位内幕人士 · 18 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | 2026年9月18日 A | 171971 | 2 | 0 | $578318 |
| Robert M Vanhimbergen | EVP and CFO | 2026年9月18日 A | 137516 | 2 | 0 | $247334 |
| Todd S. Young | Executive Vice President and Chief Financial Officer | 2025年3月3日 A | 200969 | 0 | 0 | $0 |
| Rajeev A. Modi | Executive Vice President U.S. Pet Health and Global Digital Transformation | 2026年9月18日 A | 160812 | 2 | 0 | $195924 |
| Shiv O'Neill | GC AND CORP SEC | 2026年8月18日 P | 87832 | 1 | 0 | $94273 |
| David S Kinard | Executive Vice President, Human Resources, Corporate Affairs and Administration | 2026年7月1日 A | 214264 | 0 | 0 | $0 |
| Ellen De Brabander | Executive Vice President, Research, Development and Regulatory Affairs | 2026年4月1日 F | 280821 | 0 | 0 | $0 |
| De Simas Jose Manuel Correia | Executive Vice President, US Farm Animal Business | 2026年3月6日 A | 101017 | 0 | 0 | $0 |
| Grace Mcardle | EVP, MANUFACTURING AND QUALITY | 2026年3月3日 F | 103705 | 0 | 0 | $0 |
| Timothy J Bettington | Executive Vice President, Center of Strategic Growth | 2026年3月3日 F | 143261 | 0 | 0 | $0 |
| James M Meer | CHIEF ACCOUNTING OFFICER | 2026年3月3日 F | 66732 | 0 | 0 | $0 |
| Ramiro Martin Cabral | Executive Vice President - Elanco International | 2026年3月3日 F | 283874 | 0 | 0 | $0 |
| Marcela A. Kirberger | Executive Vice President, General Counsel and Corporate Secretary | 2023年7月1日 F | 47016 | 0 | 0 | $0 |
| David Alan Urbanek | Executive Vice President, Manufacturing and Quality | 2023年3月2日 F | 133294 | 0 | 0 | $0 |
| Dirk Ehle | Ex VP & Pres Elanco Europe | 2021年11月30日 F | 11241 | 0 | 0 | $0 |
| Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | 2021年11月30日 F | 34628 | 0 | 0 | $0 |
| Michael-Bryant Hicks | Executive Vice President, General Counsel and Corporate Secretary | 2021年3月2日 F | 55588 | 0 | 0 | $0 |
| Sarena S Lin | Executive Vice President, Elanco USA, Global Marketing, Corporate Strategy and Transformation | 2020年3月2日 A | 66051 | 0 | 0 | $0 |
| Kapila K Anand | 董事 | 2026年9月30日 A | 111847 | 0 | 0 | $0 |
| Lawrence E. Kurzius | 董事 | 2026年8月20日 P | 188647 | 2 | 0 | $1149000 |
| Michael J Harrington | 董事 | 2026年8月12日 P | 131451 | 1 | 0 | $109100 |
| Stacey Ma | 董事 | 2026年5月21日 A | 29727 | 0 | 0 | $0 |
| Kirk P Mcdonald | 董事 | 2026年5月21日 A | 105588 | 0 | 0 | $0 |
| Deborah Turner Kochevar | 董事 | 2026年5月21日 A | 94392 | 0 | 0 | $0 |
| David R Hoover | 董事 | 2026年5月21日 A | 111451 | 0 | 0 | $0 |
| Art A Garcia | 董事 | 2026年5月21日 A | 108152 | 0 | 0 | $0 |
| Craig S. Wallace | 董事 | 2024年11月29日 A | 13838 | 0 | 0 | $0 |
| Kathy V Turner | 董事 | 2024年11月29日 A | 13838 | 0 | 0 | $0 |
| John P Bilbrey | 董事 | 2024年11月29日 A | 78400 | 0 | 0 | $0 |
| William F Doyle | 董事 | 2024年11月29日 A | 94499 | 0 | 0 | $0 |
| Eli Lilly and Company | 10% 所有者 | 2019年3月11日 D | 0 | 0 | 0 | $0 |
| Paul Herendeen | · | 2026年8月7日 P | 111687 | 1 | 0 | $236800 |
| Denise Scots-Knight | · | 2026年5月21日 A | 105588 | 0 | 0 | $0 |
| Aaron L Schacht | · | 2021年10月20日 F | 78747 | 0 | 0 | $0 |
| Racquel Harris Mason | · | 2021年7月1日 F | 23770 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 72 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IHE · iShares Trust | 2.61% | 1848654 SH | 2026年9月11日 | 每日 |
| IWLG · New York Life Investments Active ... | 1.48% | 174512 NS | 2026年7月31日 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.31% | 10270 NS | 2026年7月31日 | N-PORT |
| XMMO · Invesco Exchange-Traded Fund Trust | 1.14% | 3718029 SH | 2026年10月2日 | 每日 |
| LSEQ · Harbor ETF Trust | 0.97% | 5649 NS | 2026年7月31日 | N-PORT |
| PAMC · Pacer Funds Trust | 0.80% | 16309 NS | 2026年7月31日 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0.73% | 112973 SH | 2026年10月2日 | 每日 |
| BSJS · Invesco Exchange-Traded Self-Inde... | 0.73% | 5599000 | 2026年10月2日 | 每日 |
| PDP · Invesco Exchange-Traded Fund Trust | 0.65% | 444287 SH | 2026年10月2日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.64% | 1993365 NS | 2026年7月31日 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.64% | 492816 SH | 2026年8月19日 | 每日 |
| FDMO · FIDELITY COVINGTON TRUST | 0.64% | 218491 NS | 2026年7月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.54% | 261657 NS | 2026年7月31日 | N-PORT |
| FNY · First Trust Exchange-Traded Alpha... | 0.51% | 111889 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.50% | 2765631 NS | 2026年7月31日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.49% | 61478 NS | 2026年7月31日 | N-PORT |
| PTMC · Pacer Funds Trust | 0.37% | 54996 NS | 2026年7月31日 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.36% | 67550 SH | 2026年10月2日 | 每日 |
| FFSM · FIDELITY COVINGTON TRUST | 0.34% | 195287 NS | 2026年7月31日 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.34% | 807018 SH | 2026年8月19日 | 每日 |
| JOYT · J.P. Morgan Exchange-Traded Fund ... | 0.34% | 12410 NS | 2026年7月31日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.33% | 81222 NS | 2026年7月31日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.31% | 54486 NS | 2026年7月31日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.28% | 7335 NS | 2026年7月31日 | N-PORT |
| ESML · iShares Trust | 0.27% | 333623 SH | 2026年9月11日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.27% | 208323 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.26% | 7272038 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.26% | 1503184 NS | 2026年7月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.25% | 240566 NS | 2026年7月31日 | N-PORT |
| FNX · First Trust Exchange-Traded Alpha... | 0.24% | 125562 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.20% | 84441 SH | 2026年9月11日 | 每日 |
| RWK · Invesco Exchange-Traded Fund Trus... | 0.19% | 111551 SH | 2026年10月2日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.19% | 237703 NS | 2026年7月31日 | N-PORT |
| IYH · iShares Trust | 0.18% | 288878 SH | 2026年9月11日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.18% | 144799 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.18% | 1501020 SH | 2026年8月19日 | 每日 |
| SMMD · iShares Trust | 0.16% | 263707 SH | 2026年9月11日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.15% | 33594 NS | 2026年7月31日 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.15% | 11454764 SH | 2026年8月19日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.14% | 5729936 SH | 2026年8月19日 | 每日 |
| IWS · iShares Trust | 0.11% | 740543 SH | 2026年9月11日 | 每日 |
| WSML · iShares Trust | 0.10% | 30253 SH | 2026年9月11日 | 每日 |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.09% | 33069 SH | 2026年10月2日 | 每日 |
| IWR · iShares Trust | 0.08% | 2021822 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.07% | 403113 NS | 2026年7月31日 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0.06% | 165538 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.06% | 1095995 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.06% | 11823 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.04% | 49974 NS | 2026年7月31日 | N-PORT |
| IUSG · iShares Trust | 0.03% | 444256 SH | 2026年9月11日 | 每日 |
| IWD · iShares Trust | 0.03% | 1096486 SH | 2026年9月11日 | 每日 |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.03% | 13398 SH | 2026年10月2日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 298479 SH | 2026年8月19日 | 每日 |
| TILT · FlexShares Trust | 0.03% | 22278 NS | 2026年7月31日 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 115978 SH | 2026年10月2日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.02% | 112598 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.02% | 161701 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 15875248 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 82534 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 41532 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.02% | 111780 SH | 2026年8月19日 | 每日 |
| IYY · iShares Trust | 0.02% | 21753 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.02% | 339204 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.02% | 660041 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.02% | 133576 SH | 2026年9月11日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 428791 SH | 2026年8月19日 | 每日 |
| IJH · iShares Trust | · | 17525227 SH | 2026年9月11日 | 每日 |
| IJK · iShares Trust | · | 2892074 SH | 2026年9月11日 | 每日 |
| XJH · iShares Trust | · | 68229 SH | 2026年9月8日 | 每日 |
| ISCB · iShares Trust | · | 21431 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 46293 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 249706 SH | 2026年9月11日 | 每日 |
ELAN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
13 位分析师 · 2026-09-30平均目标 $31.00 +39.8%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| BLTE | $6.29B | -69.2 | · | · | -16.9% | · |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。